Is it a good idea to buy ardelyx now and sell before market

**Ardelyx (ARDX) presents a speculative buy opportunity**, considering the following points:

1. **Recent Price Movement**: ARDX has experienced a significant price increase of 10.31% on June 28, 2024, closing at $7.17. This surge could be indicative of positive market sentiment or reactions to recent company news or broader market trends.

2. **Company Developments**: Ardelyx has been actively participating in conferences and presenting data on its product pipeline, which could be generating interest and potentially driving the stock price. Additionally, the company has reported earnings and revenue surprises, which could be viewed positively by investors.
3. **Analyst Ratings**: Despite the recent price increase, ARDX's current valuation is still considered undervalued by Wall Street analysts. This could suggest that there is potential for further price appreciation as the market adjusts its valuation.
4. **Financial Performance**: Ardelyx reported a Q1 loss but topped revenue estimates, which could be seen as a mixed signal. However, the company's ability to exceed revenue expectations could be a sign of improving financial performance.
5. **Market Conditions**: The broader market conditions and news related to the biopharmaceutical sector could impact ARDX's performance. Positive developments in the industry or favorable news related to Ardelyx's pipeline could drive the stock price higher.
6. **Investment Considerations**: As with any speculative buy, there is inherent